Literature DB >> 19590577

Overgrowth of a mouse model of Simpson-Golabi-Behmel syndrome is partly mediated by Indian hedgehog.

Mariana I Capurro1, Fuchuan Li, Jorge Filmus.   

Abstract

Loss-of-function mutations of Glypican 3 (Gpc3) cause the Simpson-Golabi-Behmel overgrowth syndrome (SGBS), and developmental overgrowth is observed in Gpc3-null mice, a mouse model for SGBS. We recently reported that GPC3 inhibits Hedgehog (Hh) signalling by inducing its endocytosis and degradation. Here, we show that the developmental overgrowth observed in Gpc3-null mice is, at least in part, a consequence of the hyperactivation of the Hh pathway. We bred Gpc3-null mice with mice that are Hh signalling-deficient owing to the lack of Indian Hh (Ihh), one of the three mammalian Hhs. We found that the Gpc3-null mice showed a 29.9% overgrowth in an Ihh wild-type background, whereas an Ihh-null background partly rescues the overgrowth caused by the lack of Gpc3 as the double mutants were 19.8% bigger than the Ihh-null mice. Consistent with the role of GPC3 in Hh endocytosis and degradation, the Gpc3-null mice show increased levels of Ihh protein and signalling, but similar levels of Ihh messenger RNA.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19590577      PMCID: PMC2726674          DOI: 10.1038/embor.2009.98

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  21 in total

1.  Identification of Hedgehog pathway components by RNAi in Drosophila cultured cells.

Authors:  Lawrence Lum; Shenqin Yao; Brian Mozer; Alessandra Rovescalli; Doris Von Kessler; Marshall Nirenberg; Philip A Beachy
Journal:  Science       Date:  2003-03-28       Impact factor: 47.728

Review 2.  Developmental regulation of the growth plate.

Authors:  Henry M Kronenberg
Journal:  Nature       Date:  2003-05-15       Impact factor: 49.962

3.  Overgrowth of a mouse model of the Simpson-Golabi-Behmel syndrome is independent of IGF signaling.

Authors:  Eric Chiao; Peter Fisher; Laura Crisponi; Manila Deiana; Ioannis Dragatsis; David Schlessinger; Giuseppe Pilia; Argiris Efstratiadis
Journal:  Dev Biol       Date:  2002-03-01       Impact factor: 3.582

4.  glypican-3 controls cellular responses to Bmp4 in limb patterning and skeletal development.

Authors:  S Paine-Saunders; B L Viviano; J Zupicich; W C Skarnes; S Saunders
Journal:  Dev Biol       Date:  2000-09-01       Impact factor: 3.582

5.  Ihh signaling is directly required for the osteoblast lineage in the endochondral skeleton.

Authors:  Fanxin Long; Ung-il Chung; Shinsuke Ohba; Jill McMahon; Henry M Kronenberg; Andrew P McMahon
Journal:  Development       Date:  2004-02-18       Impact factor: 6.868

Review 6.  Nevoid basal cell carcinoma syndrome.

Authors:  R J Gorlin
Journal:  Dermatol Clin       Date:  1995-01       Impact factor: 3.478

7.  Drosophila glypicans control the cell-to-cell movement of Hedgehog by a dynamin-independent process.

Authors:  Chun Han; Tatyana Y Belenkaya; Bei Wang; Xinhua Lin
Journal:  Development       Date:  2004-01-07       Impact factor: 6.868

8.  Glypican-3 inhibits Hedgehog signaling during development by competing with patched for Hedgehog binding.

Authors:  Mariana I Capurro; Ping Xu; Wen Shi; Fuchuan Li; Angela Jia; Jorge Filmus
Journal:  Dev Cell       Date:  2008-05       Impact factor: 12.270

9.  The glypican Dally-like is required for Hedgehog signalling in the embryonic epidermis of Drosophila.

Authors:  Sabrina C Desbordes; Bénédicte Sanson
Journal:  Development       Date:  2003-11-05       Impact factor: 6.868

10.  Genetic manipulation of hedgehog signaling in the endochondral skeleton reveals a direct role in the regulation of chondrocyte proliferation.

Authors:  F Long; X M Zhang; S Karp; Y Yang; A P McMahon
Journal:  Development       Date:  2001-12       Impact factor: 6.868

View more
  19 in total

Review 1.  Advances in liver cancer antibody therapies: a focus on glypican-3 and mesothelin.

Authors:  Mitchell Ho
Journal:  BioDrugs       Date:  2011-10-01       Impact factor: 5.807

2.  Aptamers against Cells Overexpressing Glypican 3 from Expanded Genetic Systems Combined with Cell Engineering and Laboratory Evolution.

Authors:  Liqin Zhang; Zunyi Yang; Thu Le Trinh; I-Ting Teng; Sai Wang; Kevin M Bradley; Shuichi Hoshika; Qunfeng Wu; Sena Cansiz; Diane J Rowold; Christopher McLendon; Myong-Sang Kim; Yuan Wu; Cheng Cui; Yuan Liu; Weijia Hou; Kimberly Stewart; Shuo Wan; Chen Liu; Steven A Benner; Weihong Tan
Journal:  Angew Chem Int Ed Engl       Date:  2016-09-07       Impact factor: 15.336

3.  Faulty initiation of proteoglycan synthesis causes cardiac and joint defects.

Authors:  Sevjidmaa Baasanjav; Lihadh Al-Gazali; Taishi Hashiguchi; Shuji Mizumoto; Bjoern Fischer; Denise Horn; Dominik Seelow; Bassam R Ali; Samir A A Aziz; Ruth Langer; Ahmed A H Saleh; Christian Becker; Gudrun Nürnberg; Vincent Cantagrel; Joseph G Gleeson; Delphine Gomez; Jean-Baptiste Michel; Sigmar Stricker; Tom H Lindner; Peter Nürnberg; Kazuyuki Sugahara; Stefan Mundlos; Katrin Hoffmann
Journal:  Am J Hum Genet       Date:  2011-07-15       Impact factor: 11.025

Review 4.  The Role of Glypicans in Cancer Progression and Therapy.

Authors:  Nan Li; Madeline R Spetz; Mitchell Ho
Journal:  J Histochem Cytochem       Date:  2020-07-06       Impact factor: 2.479

Review 5.  Control of mammalian kidney development by the Hedgehog signaling pathway.

Authors:  Jason E Cain; Norman D Rosenblum
Journal:  Pediatr Nephrol       Date:  2010-12-15       Impact factor: 3.714

Review 6.  Glypican-3: a new target for cancer immunotherapy.

Authors:  Mitchell Ho; Heungnam Kim
Journal:  Eur J Cancer       Date:  2010-11-26       Impact factor: 9.162

7.  LRP1 mediates Hedgehog-induced endocytosis of the GPC3-Hedgehog complex.

Authors:  Mariana I Capurro; Wen Shi; Jorge Filmus
Journal:  J Cell Sci       Date:  2012-03-30       Impact factor: 5.285

Review 8.  Glypicans as Cancer Therapeutic Targets.

Authors:  Nan Li; Wei Gao; Yi-Fan Zhang; Mitchell Ho
Journal:  Trends Cancer       Date:  2018-09-28

Review 9.  Glypican-3 antibodies: a new therapeutic target for liver cancer.

Authors:  Mingqian Feng; Mitchell Ho
Journal:  FEBS Lett       Date:  2013-10-15       Impact factor: 4.124

10.  Drosophila Glypicans Regulate Follicle Stem Cell Maintenance and Niche Competition.

Authors:  Tsu-Yi Su; Eriko Nakato; Pui Yee Choi; Hiroshi Nakato
Journal:  Genetics       Date:  2018-04-09       Impact factor: 4.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.